(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.50%) $78.87
(0.27%) $2.20
(0.06%) $2 332.50
(0.11%) $27.65
(0.18%) $966.60
(0.04%) $0.929
(0.01%) $10.83
(0.04%) $0.796
(0.00%) $91.34
0.19% INR 104.00
Live Chart Being Loaded With Signals
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally...
Stats | |
---|---|
Объем за сегодня | 499 292 |
Средний объем | 1.05M |
Рыночная капитализация | 17.42B |
EPS | INR0 ( 2024-02-09 ) |
Дата следующего отчета о доходах | ( INR0 ) 2024-05-20 |
Last Dividend | INR0.450 ( 2016-07-28 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -452.17 |
ATR14 | INR0.0690 (0.07%) |
Объем Корреляция
Camlin Fine Sciences Корреляция
10 Самые положительные корреляции | |
---|---|
CENTUM.NS | 0.816 |
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Camlin Fine Sciences Корреляция - Валюта/Сырье
Camlin Fine Sciences Финансовые показатели
Annual | 2022 |
Выручка: | INR16.82B |
Валовая прибыль: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Выручка: | INR16.82B |
Валовая прибыль: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Выручка: | INR14.09B |
Валовая прибыль: | INR6.40B (45.43 %) |
EPS: | INR4.65 |
FY | 2021 |
Выручка: | INR11.81B |
Валовая прибыль: | INR5.86B (49.64 %) |
EPS: | INR4.13 |
Financial Reports:
No articles found.
Camlin Fine Sciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.450 | 2015-07-27 |
Last Dividend | INR0.450 | 2016-07-28 |
Next Dividend | INR0 | N/A |
Payout Date | 2016-09-10 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR0.900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.84 | -- |
Div. Sustainability Score | 0.424 | |
Div.Growth Potential Score | 1.741 | |
Div. Directional Score | 1.082 | -- |
Year | Amount | Yield |
---|---|---|
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PTC.NS | Dividend Knight | 2023-09-20 | Annually | 21 | 6.06% | |
KDDL.NS | Dividend Junior | 2023-09-22 | Annually | 8 | 0.29% | |
ELDEHSG.NS | Dividend Junior | 2023-09-15 | Annually | 3 | 0.63% | |
AHLADA.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.95% | |
SUNDARMHLD.NS | Dividend Junior | 2023-07-03 | Annually | 7 | 1.35% | |
NATIONALUM.NS | Dividend Knight | 2023-09-15 | Semi-Annually | 26 | 4.12% | |
HLEGLAS.NS | Dividend Junior | 2023-09-21 | Annually | 4 | 0.19% | |
CANTABIL.NS | Dividend Junior | 2023-09-15 | Annually | 5 | 0.63% | |
RITES.NS | Dividend Knight | 2023-09-08 | Quarterly | 7 | 3.95% | |
LAMBODHARA.NS | Dividend Junior | 2023-09-14 | Annually | 10 | 0.87% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00394 | 1.500 | -0.0788 | -0.118 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.00732 | 1.500 | -1.192 | -1.789 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.418 | 1.000 | -0.586 | -0.586 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 6.43 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.473 | 1.000 | 5.45 | 5.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0248 | 1.000 | -1.504 | -1.504 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.424 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -266.23 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.00732 | 2.50 | -0.767 | -1.789 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 8.04 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0729 | 1.000 | -0.677 | 0 | [0.1 - 0.5] |
Total Score | 1.741 |
Camlin Fine Sciences
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа